Lipid formulated compositions and methods for inhibiting expression of EG5 and VEGF genes

This invention relates to compositions containing double- stranded ribonucleic acid (dsRNA) in a liquid particle formulation, methods of using the compositions to inhibit the expression of the Eg5/KSPand VEGF, and methods of using the compositions to treat pathological processes mediated by Eg5/KSP...

Full description

Saved in:
Bibliographic Details
Main Authors VAISHNAW AKSHAY, GOLLOB JARED, GAMBA-VITALO CHRISTINA, SAH DINAH WEN-YEE
Format Patent
LanguageChinese
English
Published 16.08.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This invention relates to compositions containing double- stranded ribonucleic acid (dsRNA) in a liquid particle formulation, methods of using the compositions to inhibit the expression of the Eg5/KSPand VEGF, and methods of using the compositions to treat pathological processes mediated by Eg5/KSP and VEGF expression, such as endometrial cancer. 本发明涉及在液体颗粒制剂中含有双链核糖核酸(dsRNA)的组合物,利用该组合物抑制Eg5/KSP和VEGF的表达的方法,以及利用该组合物治疗由Eg5/KSP和VEGF表达介导的病理过程例如子宫内膜癌的方法。
Bibliography:Application Number: CN201910354127